Unmet needs in myelofibrosis

Naveen Pemmaraju, MD, University of Texas MD Anderson Cancer Center, Houston, TX, reflects on areas of unmet need for patients with myelofibrosis (MF). Dr Pemmaraju discusses the importance of minimizing toxicities associated wth combination approaches, measuring myeloproliferative neoplasms symptom burden, and disease modification. This interview took place at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting in Chicago, IL.